ESC 365 - Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study.

ESC Professional Premium Access

Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study.

Session: Right and left heart disease: which comes first?

Topic: Pulmonary Hypertension

Speaker: Doctor M. Toma (Genoa, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Matteo Toma

IRCCS Policlinic San Martino, Genoa (Italy)

1 presentation

0 follower

4 more presentations in this session

Validation of the OPTICS and H2FPEF risk scores for post-capillary pulmonary hypertension in an asian cohort

Speaker: Mr H. Jiang (Singapore, SG)

PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension

Speaker: Doctor T. Hofbauer (Vienna, AT)

Pulmonary hypertension in patients with heart failure with reduced ejection fraction: impact of the new definition of pulmonary hypertension

Speaker: Doctor S. Vysocansky (Bratislava, SK)

Pulmonary hypertension associated with left heart disease among hospitalized patients: analysis of the Nationwide Inpatient Sample

Speaker: Mr I. Farmakis (Mainz, DE)

Access the full session

Right and left heart disease: which comes first?

Speakers: Doctor M. Toma, Mr H. Jiang, Doctor T. Hofbauer, Doctor S. Vysocansky, Mr I. Farmakis

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources